1 / 1

80 -

Supplemental Figure 1. HA-Ub + + + Hypoxia + - + MG132 + + +. IP: IgG VHL. kDa 118 -. Ub-VHL. 80 -. 68 -. 48 -. 30 -. 25 -. IB: a-HA. blot: HA. 68 -. 48 -. 30 -.  p25 VHL. 25 -.  p19 VHL. 17 -. blot: VHL.

amie
Download Presentation

80 -

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Supplemental Figure 1 HA-Ub + + + Hypoxia + - + MG132 + + + IP: IgG VHL kDa 118 - Ub-VHL 80 - 68 - 48 - 30 - 25 - IB: a-HA blot: HA 68 - 48 - 30 -  p25 VHL 25 -  p19 VHL 17 - blot: VHL 786-O G7F cells were transfected with an HA-Ubiquitin expression vector. Twenty four hours later, transfected cells were treated with MG-132 10 mM and with hypoxia or normoxia for 8 hours. Cells were lysed with NP40 buffer and immunoprecipitation was performed with anti-VHL (Ig32) antibody and western blot was further performed with anti-HA (Y11) (top panel) or anti-VHL (Ig32) (bottom panel), respectively.

More Related